← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2015Last known activity
Jul 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 6 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT06276231OfficialN/AJul 1, 2024
- NCT06315920OfficialPhase 3May 1, 2024
- NCT06315920CollaboratorPhase 3May 1, 2024
- NCT06000462Lead sponsorPhase 2/Phase 3Dec 31, 2023
- NCT06000462Reponsible party - principal investigatorPhase 2/Phase 3Dec 31, 2023
- NCT06000462Sponsor investigatorPhase 2/Phase 3Dec 31, 2023
- NCT07074821Lead sponsorPhase 2Mar 1, 2023
- NCT07074821Sponsor investigatorPhase 2Mar 1, 2023
- NCT04465175Overall official - principal investigatorPhase 2/Phase 3Aug 31, 2020
- NCT02525107CollaboratorPhase 3Sep 1, 2015
Details
- Last known activity
- Jul 1, 2024